Lymphocyte Immunophenotyping in Common Variable Immunodeficiency
Investigation of the Lymphocyte Surface Expression of Patients With Primary Immunodeficiency (Common Variable Immunodeficiency (CVID)), Compared to Controls
Sponsor: Barts & The London NHS Trust
Listed as NCT01196702, this observational or N/A phase trial focuses on Bronchiectasis and Common Variable Immunodeficiency and remains completed. Sponsored by Barts & The London NHS Trust, it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2023 — Apr 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Dec 2021 — Jan 2023 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Barts & The London NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .